Marketable Securities (Tables)

9 Months Ended

Mar. 31, 2025

Marketable Securities

Schedule of investment in marketable securities

	March 31, 2025		June 30, 2024
Equity Securities	$	5,748	$	5,398
Debt Securities (available-for-sale)		10,136		—
	$	15,884	$	5,398

Schedule of net gains and losses on the equity securities

The disaggregated net gains and losses on the equity securities recognized within the accompanying condensed consolidated statements of income for the three and nine months ended March 31, 2025 and 2024, are as follows (in thousands):

	Three months ended March 31,				Nine months ended March 31,
	2025		2024		2025		2024
Net gains recognized during the period on equity securities	$	51	$	42	$	219	$	160
Unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date		49		(18)		131		52
	$	100	$	24	$	350	$	212

Schedule of investments in equity securities

The following tables summarize the Company’s investments in equity securities at March 31, 2025 and June 30, 2024, respectively (in thousands):

	March 31, 2025						June 30, 2024
					Unrealized						Unrealized
	Cost		Fair Value		Gain (Loss)		Cost		Fair Value		Gain (Loss)
Mutual Funds	$	5,951		5,748	$	(203)	$	5,857	$	5,398	$	(459)

Schedule of investment in debt securities

The Company had no investment in debt securities at June 30, 2024. The following tables summarize the Company’s investments in debt securities at March 31, 2025 (in thousands):

	Amortized Cost		Unrealized Gains		Unrealized Losses		Aggregate Fair Value
U.S. Treasury Securities	$	10,003	$	133	$	—	$	10,136